Javascript must be enabled to continue!
Disparities in esophageal cancer incidence and esophageal adenocarcinoma mortality in the United States over the last 25-40 years
View through CrossRef
BACKGROUND
Esophageal carcinoma presents as 2 types, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC) with the frequency of both changing in the United States (US).
AIM
To investigate EAC/ESCC incidence time trends among the 3 main US racial groups and investigate trends in US EAC survival by ethnicity.
METHODS
Twenty-five years (1992-2016) of data from SEER 13 program was analyzed to compare incidence trends in EAC and ESCC between non-Hispanic whites (nHW), non-Hispanic Blacks (nHB) and Hispanics (Hisp) using SEERStat® . In addition, SEER 18 data, from 1975-2015, on EAC in the US was analyzed to evaluate racial disparities in incidence and survival using SEERStat® and Ederer II method.
RESULTS
In the 3 major US ethnic groups, age-adjusted incidence of ESCC has declined while EAC has continued to rise from 1992-2016. Of note, in Hisp, the EAC incidence rate increased while ESCC decreased from 1992 to 2016, resulting in EAC as the predominant esophageal cancer subtype in this group since 2011, joining nHW. Furthermore, although ESCC remains the predominant tumor in nHB, the difference between ESCC and EAC has narrowed dramatically over 25 years. EAC survival probabilities were worse in all minority groups compared to nHw.
CONCLUSION
Hisp have joined nHW as US ethnic groups more likely to have EAC than ESCC. Of note, EAC incidence in nHB is increasing at the highest rate nationally. Despite lower EAC incidence in all minority groups compared to nHW, these populations have decreased survival compared to nHW.
Baishideng Publishing Group Inc.
Title: Disparities in esophageal cancer incidence and esophageal adenocarcinoma mortality in the United States over the last 25-40 years
Description:
BACKGROUND
Esophageal carcinoma presents as 2 types, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC) with the frequency of both changing in the United States (US).
AIM
To investigate EAC/ESCC incidence time trends among the 3 main US racial groups and investigate trends in US EAC survival by ethnicity.
METHODS
Twenty-five years (1992-2016) of data from SEER 13 program was analyzed to compare incidence trends in EAC and ESCC between non-Hispanic whites (nHW), non-Hispanic Blacks (nHB) and Hispanics (Hisp) using SEERStat® .
In addition, SEER 18 data, from 1975-2015, on EAC in the US was analyzed to evaluate racial disparities in incidence and survival using SEERStat® and Ederer II method.
RESULTS
In the 3 major US ethnic groups, age-adjusted incidence of ESCC has declined while EAC has continued to rise from 1992-2016.
Of note, in Hisp, the EAC incidence rate increased while ESCC decreased from 1992 to 2016, resulting in EAC as the predominant esophageal cancer subtype in this group since 2011, joining nHW.
Furthermore, although ESCC remains the predominant tumor in nHB, the difference between ESCC and EAC has narrowed dramatically over 25 years.
EAC survival probabilities were worse in all minority groups compared to nHw.
CONCLUSION
Hisp have joined nHW as US ethnic groups more likely to have EAC than ESCC.
Of note, EAC incidence in nHB is increasing at the highest rate nationally.
Despite lower EAC incidence in all minority groups compared to nHW, these populations have decreased survival compared to nHW.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Nyelőcső-adenocarcinoma.
Nyelőcső-adenocarcinoma.
Összefoglaló. Az 1970-es évek előtt a nyelőcsőrákok csupán 1–3%-a
volt adenocarcinoma. A 70-es évek közepétől a nyelőcső-adenocarcinoma mutatta a
...
Abstract B46: Cancer incidence and mortality rates and trends in Trinidad and Tobago
Abstract B46: Cancer incidence and mortality rates and trends in Trinidad and Tobago
Abstract
Background: Consistent with observations from various developing regions of the world, cancer incidence and mortality rates have increased in the past two d...
Abstract 1425: Significance of Dickkopf-3 overexpression in the pathogenesis of esophageal adenocarcinoma
Abstract 1425: Significance of Dickkopf-3 overexpression in the pathogenesis of esophageal adenocarcinoma
Abstract
Ninety percent of those diagnosed with esophageal adenocarcinoma ultimately die of their disease highlighting the need for novel therapeutic targets. In ord...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Decreasing Trend of Esophageal Adenocarcinoma in Hong Kong
Decreasing Trend of Esophageal Adenocarcinoma in Hong Kong
Abstract
Background: The incidence of esophageal adenocarcinoma was increasing in the Western Europe and United States, but not in East Asian countries. Population b...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract 5210: Incidence and mortality trends of prostate cancer in southern Thailand
Abstract 5210: Incidence and mortality trends of prostate cancer in southern Thailand
Abstract
Background: Prostate cancer is one of the most commonly diagnosed cancers in men worldwide. In Asia, the incidence of prostate cancer is expected to increas...

